ATE209184T1 - In 6-s und/oder 8-s durch 3- methylthiopropanoylrest substituierte 6,8- dimethylmercaptooctansäure-derivate und pharmaceutische zubereitungen zur behandlung von krebstumoren - Google Patents

In 6-s und/oder 8-s durch 3- methylthiopropanoylrest substituierte 6,8- dimethylmercaptooctansäure-derivate und pharmaceutische zubereitungen zur behandlung von krebstumoren

Info

Publication number
ATE209184T1
ATE209184T1 AT99400803T AT99400803T ATE209184T1 AT E209184 T1 ATE209184 T1 AT E209184T1 AT 99400803 T AT99400803 T AT 99400803T AT 99400803 T AT99400803 T AT 99400803T AT E209184 T1 ATE209184 T1 AT E209184T1
Authority
AT
Austria
Prior art keywords
methylthiopropanoyl
acid derivatives
dimethylmercaptooctanic
rest
treatment
Prior art date
Application number
AT99400803T
Other languages
English (en)
Inventor
Gerard Anthony Quash
Jacques Gore
Guy Fournet
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Application granted granted Critical
Publication of ATE209184T1 publication Critical patent/ATE209184T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99400803T 1998-04-01 1999-04-01 In 6-s und/oder 8-s durch 3- methylthiopropanoylrest substituierte 6,8- dimethylmercaptooctansäure-derivate und pharmaceutische zubereitungen zur behandlung von krebstumoren ATE209184T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9804041A FR2777001B1 (fr) 1998-04-01 1998-04-01 Derives de l'acide 6,8-dimercaptooctanoique substitues en 6-s et/ou en 8-s par le radical (3-methylthiopropanoyl) et compositions pharmaceutiques destinees au traitement des tumeurs cancereuses

Publications (1)

Publication Number Publication Date
ATE209184T1 true ATE209184T1 (de) 2001-12-15

Family

ID=9524740

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99400803T ATE209184T1 (de) 1998-04-01 1999-04-01 In 6-s und/oder 8-s durch 3- methylthiopropanoylrest substituierte 6,8- dimethylmercaptooctansäure-derivate und pharmaceutische zubereitungen zur behandlung von krebstumoren

Country Status (11)

Country Link
US (1) US6117902A (de)
EP (1) EP0947503B1 (de)
JP (1) JP3459884B2 (de)
AT (1) ATE209184T1 (de)
AU (1) AU747867C (de)
CA (1) CA2264985C (de)
DE (1) DE69900698T2 (de)
DK (1) DK0947503T3 (de)
ES (1) ES2167989T3 (de)
FR (1) FR2777001B1 (de)
PT (1) PT947503E (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6001299A (en) * 1998-10-02 2000-04-26 Sankyo Company Limited Dithiol derivatives
ATE277034T1 (de) * 1998-10-26 2004-10-15 Univ New York State Res Found Liponsaürederivate und deren verwendung bei der behandlung von krankheiten
FR2809727B1 (fr) * 2000-05-31 2002-07-26 Galderma Res & Dev Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US7078402B2 (en) * 2000-05-31 2006-07-18 Centre National De La Recherche Scientifique (Cnrs) Aminothiol ester compounds, pharmaceutical and cosmetics compositions containing same and uses thereof
US6916892B2 (en) * 2001-12-03 2005-07-12 Fina Technology, Inc. Method for transitioning between Ziegler-Natta and metallocene catalysts in a bulk loop reactor for the production of polypropylene
US8263653B2 (en) 2007-04-18 2012-09-11 Cornerstone Pharmaceuticals, Inc. Pharmaceutical formulations containing lipoic acid derivatives
MX2009011316A (es) * 2007-04-18 2010-03-26 Cornerstone Pharmaceuticals Inc Derivados del acido lipoico.
WO2008131114A2 (en) 2007-04-18 2008-10-30 Cornerstone Pharmaceuticals, Inc. Pharmaceutical formulations containing lipoic acid derivatives
KR20110025168A (ko) * 2008-04-04 2011-03-09 로버트 쇼어 약학적 조성물
AU2014398233B2 (en) 2014-06-19 2019-11-28 Rafael Pharmaceuticals, Inc. Pharmaceutical compounds
EP3189033B1 (de) 2014-06-19 2020-08-05 Rafael Pharmaceuticals, Inc. Pharmazeutische verbindungen
DK3362094T3 (da) * 2015-10-15 2021-03-01 Advanced Biodesign Kombination omfattende en aminothiolesterforbindelse eller et farmaceutisk acceptabelt salt deraf og en forbindelse, der er i stand til at øge H2O2-niveauet i cancerceller i et individ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2728790B1 (fr) * 1994-12-29 1997-01-24 Cird Galderma Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial

Also Published As

Publication number Publication date
AU2253699A (en) 1999-10-14
JP3459884B2 (ja) 2003-10-27
FR2777001B1 (fr) 2000-06-09
JP2000001471A (ja) 2000-01-07
DE69900698T2 (de) 2002-08-08
DK0947503T3 (da) 2002-05-13
AU747867C (en) 2003-01-09
AU747867B2 (en) 2002-05-23
US6117902A (en) 2000-09-12
DE69900698D1 (de) 2002-02-21
CA2264985A1 (fr) 1999-10-01
CA2264985C (fr) 2003-12-09
EP0947503B1 (de) 2001-11-21
ES2167989T3 (es) 2002-05-16
FR2777001A1 (fr) 1999-10-08
EP0947503A1 (de) 1999-10-06
PT947503E (pt) 2002-05-31

Similar Documents

Publication Publication Date Title
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
FI913478A0 (fi) Diazinderivat.
EA200001146A1 (ru) Производные изотиазола, применимые в качестве противораковых агентов
ATE28565T1 (de) Spiro(4.(3+n))-2-aza-alkan-3-carbonsaeurederivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung.
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
NO20014925L (no) Farmasöytiske forbindelser
DE69900698D1 (de) In 6-S und/oder 8-S durch 3-Methylthiopropanoylrest substituierte 6,8-Dimethylmercaptooctansäure-Derivate und pharmaceutische Zubereitungen zur Behandlung von Krebstumoren
DE69012010D1 (de) Halogenierte Pyrimidin-3-oxid-Derivate, deren Verwendung für die Behandlung und die Verhütung von Haarausfall und für die Wachstumsförderung von Haaren.
ATE344230T1 (de) Triphenylbutenderivate zur behandlung von neurologischen störungen
ATE124686T1 (de) Phenylalkylamine und diese enthaltende fungizide.
DE68900516D1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
DE69018099D1 (de) Polyamin-Derivate als antineoplastische Mittel.
DE69634494D1 (de) Verwendung von Vitamin D Derivaten zur Herstellung eines Medikaments zur Behandlung von BÖSARTIGEN TUMORMETASTASE
ATE28639T1 (de) Derivate von 4-(3-alkynyloxy-2-hydroxy-propyl)piperazin-1-yl-n-phenylacetamid, ihre herstellung und ihre therapeutische verwendung.
ATE170520T1 (de) Eburnan-derivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE226585T1 (de) Thiazolobenzoheterocyclen, ihre herstellung und diese enthaltende phatrmazeutische zubereitungen
DE69400352D1 (de) 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel
ES533657A0 (es) Un procedimiento para la preparacion de nuevos derivados de pirrolo-(2,1-a)isoquilonina.
ATE167869T1 (de) Thiolderivate von gallensäure
FR2601364B1 (fr) Nouveaux derives de la piperazine dione-2,6, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
ATE101119T1 (de) Butensaeure-amide, deren salze, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
ATE41774T1 (de) (+)-cyanidan-3-ol derivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung.
DE68909961D1 (de) 2-Aminoacetamid Derivate.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee